ClinicalTrials.Veeva

Menu

Development of a Novel Methodology Using BMVC Staining as an Assistance to Cancer Cytological Diagnosis

F

Far Eastern Memorial Hospital

Status

Unknown

Conditions

Neck Mass

Study type

Observational

Funder types

Other

Identifiers

NCT01301690
FEMH No.:98041-3

Details and patient eligibility

About

3,6-bis(1-methyl-4-vinylpyridinium) carbazole diiodide (BMVC) is an inorganic chemical compound (Figure1). The uptake of BMVC in cancer cells and normal cells are different. Recently, a simple handheld device (Figure1) based on the fluorescence analysis of stained cells was established to instantly differentiate cancer cells from normal cells. The investigators want to quantitatively measure the fluorescence expression of BMVC in normal and cancer cells and explore the usefulness of this staining in head and neck lumps.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients (age range from 18 to 90 years old) with neck lumps, receiving sonographic examination and FNA cytologic study.

Exclusion criteria

  • No cytology data

Trial design

100 participants in 1 patient group

Neck masses
Description:
Neck mass received US and US-FNA

Trial contacts and locations

1

Loading...

Central trial contact

Li-Jen Liao, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems